BPH

Getting what you want

Personal Best

A patient you never saw can sue you

Malpractice Consult

Malpractice: 3 lessons I learned the hard way

After several narrow escapes, the author is eager to share his hard-won lessons with others.

Malpractice insurance: Better news? More choices?

As rates stabilize or even drop, doctors are rethinking their insurance options.

Patient e-mail perils

Malpractice Consult

FDA approves once-daily BPH treatment

Watson Pharmaceuticals has received FDA approval to market silodosin (Rapaflo), an alpha-blocker for the treatment of BPH signs and symptoms.

MORE ARTICLES

Idea Exchange

Idea Exchange

Tips from your colleagues

MORE ARTICLES

Retail

High Point Market Welcomes Trump Home Lines

Three home collections inspired by Donald Trump's properties and estates will be showcased at High Point Market, Oct. 20.

MORE ARTICLES

Urology

FDA approves once-daily BPH treatment

Watson Pharmaceuticals has received FDA approval to market silodosin (Rapaflo), an alpha-blocker for the treatment of BPH signs and symptoms.

MORE ARTICLES